SEC Form 5 · accession 0001762003-19-000004
Decoy Therapeutics Inc. · DCOY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Boston Foundation, Inc.
10% Owner
Period of report
Dec 31, 2018
Accepted (ET)
Feb 5, 2019 · 10:03 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001615219
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 | Jan 30, 2019 | S | 1,600,000 | $0.326 | D | 2,200,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
*Price reported of $0.326 is the weighted average price of the sales prices received for the 1,600,000 stock shares sold during the period 1/10/2019 to 1/30/2019. **This Form 5 voluntarily reports stock sales occurring after 1/9/2019, the date after Reporting Person ceased to own 10% of the Issuer as reported in Form 4 filed on 1/10/2019. As of the date of the filing of this Form 5, Reporting Person owns no shares of the Issuer.